Green decoration

MDR / IVDR Document AI

Audit-grade document AI for Swiss MedTech manufacturers. Supports your RA and QA team in preparing and maintaining MDR and IVDR technical files, PMS reports and clinical evaluation binders. Your team owns the regulatory call.

Where the engine supports your regulatory team

Technical documentation classification

Annex II technical documentation arrives from design, manufacturing, suppliers and post-market sources in mixed formats. The engine classifies each incoming document into your Annex II structure and the downstream review role, then surfaces gaps in the binder against your template. RA and QA decide what the gap means.

Post-market surveillance ingestion

Complaints, vigilance reports, field service notes and trend data feed into the PMS report template through one pipeline. The engine extracts the typed fields your PMS report expects, tags evidence against the device class, and routes anything below confidence to the reviewer. The narrative interpretation stays with the RA author.

Clinical evaluation file maintenance

Literature, post-market clinical follow-up data and equivalent-device evidence land in the clinical evaluation file with provenance preserved. The engine tags each evidence item, links it to the claim it supports, and flags gaps. The clinical reviewer signs off on every linkage.

Design history and technical file curation

DHF and TF documents accumulate across revisions. The engine indexes them by requirement, design output, verification and validation artefact, then preserves the cross-references as a queryable map. Re-ingestion of a revised document flags the downstream artefacts that need re-review.

Change-control trail on Annex II files

When a revised Annex II document is re-ingested, the engine diffs it against the prior version, surfaces the changed sections, and marks every linked downstream file as pending re-review. The change-control trail is logged with model version, prompt registry version and reviewer, so the evidence is preserved for audit.

Traceability matrix automation

Requirements, design outputs, verification and validation artefacts are linked across the binder. The engine maintains the traceability matrix as documents move through revision; QA reviews and approves the matrix at release milestones. The matrix is exportable in the format your notified body expects.

How a rollout actually runs

Your RA lead walks us through the binder structure, the Annex II / IVDR Annex II map, the downstream review roles and the systems of record. We extract the typed schema; your team validates that it mirrors the binder you defend in audit.

We pick one family with your RA lead — typically PMS reports or one Annex II section. The engine runs end-to-end on real documents: ingestion, classification, extraction, role-scoped HITL, evidence trail. RA and QA review every output before it enters the binder.

RA reviewer, QA reviewer, clinical reviewer and design owner each see only the field blocks tied to their responsibility. Every edit, role, timestamp, model version and prompt registry version is logged immutably against the source document. Separation of duties is configured up front.

Once the first family is stable, we extend the engine to the full design history file and technical file. New document families are added through the schema — no new code release. Your RA and QA team owns the binder; we maintain the engine.

Why an audit-grade engine matters here

Every decision logged with its model and prompt version

When a notified body or internal audit asks why a document was classified the way it was, the engine answers with the model ID, the prompt registry version active at the time, the reviewer and the timestamp. The evidence is not reconstructed after the fact; it is captured at decision time and preserved against the source document.

Reproducible inference at audit time

Each classification or extraction event snapshots the model and prompt registry entry it ran against. Months later, the same document can be re-run against the same snapshot and produce the same output. Reproducibility is part of the evidence trail, not a separate feature.

Role-scoped HITL with separation of duties

RA, QA, clinical and design reviewers each see only the field blocks tied to their responsibility. The reviewer who edits a field cannot be the reviewer who approves it. Separation of duties is configured against the role model, not bolted on afterwards.

Data residency in CH or EU, sovereign LLM available

The engine deploys on AWS Zurich, EU regions or your own infrastructure. Where content cannot reach a public model endpoint, the Apertus sovereign-LLM track runs the same pipeline against a Swiss-hosted model. Document content stays inside the jurisdiction your binder requires.

What this engine does not do

It does not make a device compliant. It does not replace the RA function, the QA function or the clinical reviewer. It does not represent SAPIENTROQ as a notified body or a regulatory consultancy. It supports the team that owns those calls.

Frequently Asked Questions

  • No. Regulatory compliance under MDR (EU 2017/745) and IVDR (EU 2017/746) is decided by your RA and QA team, your notified body and your conformity assessment. The engine supports your team in preparing and maintaining the documentation that backs those decisions. The regulatory call stays with the people qualified to make it.

About SAPIENTROQdecoration

ai avatar

Hey there! I’m your AI assistant developed by SAPIENTROQ. I am a language model connected to a RAG database that contains information about the company. If you need insights on AI solutions, real use cases, or how AI can boost your business, please feel free to ask in any language you prefer.

Choose an option

Hey! I am AI agent developed by SAPIENTROQ 🤖
Decoration
Decoration

Interested in a solution?

We are glad to show you various options without any obligation.

Roland Kurmann

Roland Kurmann

CEO, SAPIENTROQ

Book a call

Decoration